OMEGA THERAPEUTICS
Omega Therapeutics, Inc. is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines.
OMEGA THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.omegatherapeutics.com
Total Employee:
101+
Status:
Active
Contact:
212-600-1902
Email Addresses:
[email protected]
Total Funding:
239.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx
Similar Organizations
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Tune Therapeutics
Tune Therapeutics is an epigenetic programming platform for the treatment of disease.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
LifeSci Venture Partners
LifeSci Venture Partners investment in Series C - Omega Therapeutics
Invus
Invus investment in Series C - Omega Therapeutics
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - Omega Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series C - Omega Therapeutics
Point72
Point72 investment in Series C - Omega Therapeutics
Logos Capital
Logos Capital investment in Series C - Omega Therapeutics
Cowen and Company
Cowen and Company investment in Series C - Omega Therapeutics
BlackRock
BlackRock investment in Series C - Omega Therapeutics
Mirae Asset Capital
Mirae Asset Capital investment in Series C - Omega Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series B - Omega Therapeutics
Key Employee Changes
Official Site Inspections
http://www.omegatherapeutics.com Semrush global rank: 4.65 M Semrush visits lastest month: 2.11 K
- Host name: 66-135-26-141.constant.com
- IP address: 66.135.26.141
- Location: Lehi United States
- Latitude: 40.3942
- Longitude: -111.8483
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84043
More informations about "Omega Therapeutics"
Investors & Media | Omega Therapeutics
Jun 6, 2024 The Investor Relations website contains information about Omega Therapeutics's business for stockholders, potential investors, and financial analysts.See details»
SEC Filing | Omega Therapeutics
Mar 21, 2025 incorporation or organization) (I.R.S. Employer. Identification Number) 140 First Street, Suite 501 . Cambridge, Massachusetts 02141 (617) 949-4360 (Address, including zip …See details»
Omega Therapeutics - Crunchbase Company Profile & Funding
Omega Therapeutics, Inc. is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of …See details»
Omega Therapeutics - LinkedIn
Omega Therapeutics | 16,678 followers on LinkedIn. Pioneering the first systematic approach to using mRNA as a new class of programmable epigenomic medicines. | Omega Therapeutics …See details»
Omega Therapeutics - Overview, News & Similar companies
May 6, 2024 View Omega Therapeutics (www.omegatherapeutics.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar …See details»
Omega Therapeutics - workinbiotech.com
To develop further tools, Omega uses knowledge of the 3D-genomic organization with transcriptomics and machine learning. Currently, they have multiple programs in preclinical …See details»
Omega Therapeutics, Inc. - Drug pipelines, Patents, Clinical
Explore Omega Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 148 news, and 1 literature, Disease Domain:Neoplasms, Hemic and Lymphatic …See details»
Omega Therapeutics (OMGAQ) Company Profile & Description
May 12, 2025 Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company’s OMEGA platform enables control of fundamental epigenetic processes to …See details»
Omega Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Omega Therapeutics, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Omega Therapeutics - Craft
Oct 29, 2024 Omega Therapeutics has 1 employees at their 1 location and $3.09 m in annual revenue in FY 2023. See insights on Omega Therapeutics including office locations, …See details»
Omega Therapeutics
Omega Therapeutics focuses on precision epigenomic control for therapeutic advancements in cellular reprogramming and gene expression upregulation.See details»
Omega Therapeutics to Advance Pipeline and Platform …
Mar 30, 2021 For more information, visit omegatherapeutics.com, or follow us on Twitter and LinkedIn. Investor contact: Joseph Rayne Argot Partners 212.600.1902 [email protected] …See details»
Omega Therapeutics - Flagship Pioneering
The Company is committed to revolutionizing genomic medicine and has a pipeline of therapeutic candidates derived from its OMEGA platform spanning oncology, regenerative medicine, and …See details»
Omega Therapeutics Secures $211 Million for Groundbreaking …
Jan 13, 2025 In a significant leap forward for the field of biotechnology, Omega Therapeutics has successfully raised $211 million in funding to advance its groundbreaking research and …See details»
Omega Therapeutics - PitchBook
Omega Therapeutics General Information Description. Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to …See details»
Omega Therapeutics Announces Successful Completion of Phase 1 …
Nov 14, 2024 For more information, visit omegatherapeutics.com, or follow us on X and LinkedIn. About the OMEGA Platform The OMEGA platform leverages the Company’s deep …See details»
Omega Therapeutics - VentureRadar
"Omega Therapeutics is a clinical-stage biotechnology company pioneering a new class of DNA-sequence-targeting, mRNA-encoded therapeutics to transform human medicine.See details»
Mahesh Karande – Ashvattha Therapeutics
Mr. Karande currently serves as the President and CEO of Omega Therapeutics (Nasdaq: OMGA), a clinical-stage biotechnology company pioneering a new class of mRNA therapeutics …See details»
SEC Filing | Omega Therapeutics
On November 14, 2024, Omega Therapeutics, Inc. (the “ Company ”) entered into an Amended and Restated Shared Space Arrangement (collectively, the “ A&R SSAs ”) with each of Apriori …See details»
Omega Therapeutics Announces Promising Preliminary Clinical …
Sep 26, 2023 For more information, visit omegatherapeutics.com, or follow us on X (formerly Twitter) and LinkedIn. Forward-Looking Statements. This press release contains forward …See details»